Baviera M, Genovese S, Lepore V, Colacioppo P, et al. Lower risk of death and cardiovascular events in patients with diabetes initiating GLP-1 receptor agonists or SGLT-2 inhibitors: a real-world study on two Italian cohorts. Diabetes Obes Metab 2021 Feb 19. doi: 10.1111/dom.14361.
PMID: 33606897